| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/08/2004 | US20040131584 Complex; mondispersion of cytokine and particles |
| 07/08/2004 | US20040131583 Biocompatible polymers, process for their preparation and compositions containing them |
| 07/08/2004 | US20040131549 Contrast agents |
| 07/08/2004 | US20040131497 Process for sterilization of biological compositions containg protein |
| 07/08/2004 | US20040129112 Metal-containing materials |
| 07/08/2004 | DE202004006803U1 Kondom mit einer Beschichtung und Zusammensetzung Condom with a coating composition and |
| 07/08/2004 | CA2529816A1 Mixed esters of hyaluronic acid with retinoic and butyric acids |
| 07/08/2004 | CA2510780A1 Method of treating angiogenic tissue growth |
| 07/08/2004 | CA2509382A1 Stimuli-responsive systems for controlled drug delivery |
| 07/08/2004 | CA2508124A1 Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device |
| 07/07/2004 | EP1435389A1 Method of evaluating efficacy of nucleic acid therapy |
| 07/07/2004 | EP1435237A1 Prevention of migraine recurrence |
| 07/07/2004 | EP1435233A1 Cyclosporin-based pharmaceutical compositions |
| 07/07/2004 | EP1435232A1 Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 07/07/2004 | EP1434840A1 Low-viscosity opacifiers free from anionic surface-active agents |
| 07/07/2004 | EP1434801A2 Treatment for central nervous system disorders |
| 07/07/2004 | EP1434778A1 Cytotoxins, prodrugs, linkers and stabilizers useful therefor |
| 07/07/2004 | EP1434603A2 Method of treatment using ligand-immunogen conjugates |
| 07/07/2004 | EP1434601A2 Liposome-encapsulated insulin formulations |
| 07/07/2004 | EP1434597A1 USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY |
| 07/07/2004 | EP1434595A1 Stable solutions of peptide copper complexes and cosmetic and pharmaceutical formulations produced therefrom |
| 07/07/2004 | EP1434594A1 Cyclosporin analogs for the treatment of autoimmune diseases |
| 07/07/2004 | EP1434593A2 MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES |
| 07/07/2004 | EP1434589A2 Thioester-terminated water soluble polymers and method of modifying the n-terminus of a polypeptide therewith |
| 07/07/2004 | EP1434587A1 Pharmaceutical combinations comprising salmeterol and fluticasone proprionate for the treatment of asthma |
| 07/07/2004 | EP1434582A2 Topical composition containing brucine and the use for the treatment of damaged mammalian skin |
| 07/07/2004 | EP1434572A2 Galenic microparticulate oral formulation for delayed and controlled release of pharmaceutical active principles |
| 07/07/2004 | EP1434571A1 Particle immobilized coatings and uses thereof |
| 07/07/2004 | EP1434570A1 Pharmaceutical formulations for the controlled release of 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline |
| 07/07/2004 | EP1434568A1 Extended release pharmaceutical composition containing metformin |
| 07/07/2004 | EP1434567A1 Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid |
| 07/07/2004 | EP1434564A1 Cosmetic and/or pharmaceutical preparations |
| 07/07/2004 | EP1434556A1 Cosmetic and/or pharmaceutical preparations |
| 07/07/2004 | EP1377280A4 Bulking agents as satiety agents |
| 07/07/2004 | EP1278523B1 Combination of progesterone and mifepristone for cancer therapy |
| 07/07/2004 | EP1212093B1 Use of emu oil as a carrier for antifungal, antibacterial and antiviral medications |
| 07/07/2004 | EP1196195A4 Nasogastric enteral formulations |
| 07/07/2004 | EP1038525B1 Stabilized composition of tetrahydropyrrolo [1,2-a] pyrazine-4-spiro-3'-pyrrolidine |
| 07/07/2004 | EP0876155B1 Highly concentrated, lyophilized and liquid factor ix formulations |
| 07/07/2004 | EP0759749B1 Anti-acne compositions |
| 07/07/2004 | CN1511053A HSA-free formulations of interferon-Beta |
| 07/07/2004 | CN1511044A Elogated and multiple spacers in activatible prodrugs |
| 07/07/2004 | CN1511043A Pregabalin lactose conjugates |
| 07/07/2004 | CN1511037A Nonintestinal estramustine phosphate and albumin preparations |
| 07/07/2004 | CN1511033A Liquid drug preparations |
| 07/07/2004 | CN1511032A Toluene sulfonamide-containing anti-tumor composition and method of use thereof |
| 07/07/2004 | CN1511031A Solid pharmaceutical formulations comprising modafinil |
| 07/07/2004 | CN1511026A Granular preparations of gaboxadol |
| 07/07/2004 | CN1509718A Medicine releasing composition for improving steroid compound stability |
| 07/07/2004 | CN1156500C Process for preparing coating film material of gastric disintegrable water medicine |
| 07/07/2004 | CN1156499C Arylamine-O-quinone polymer and its prepn and use |
| 07/07/2004 | CN1156480C Water soluble SDZ-RAD esters, its preparation method, use and composition thereof |
| 07/07/2004 | CN1156461C Improved aqueous solubility pharmaceutical formulations |
| 07/07/2004 | CN1156315C One dose syringe, comprising freeze-dried protein composition, for administering of volume less than 0.5ml |
| 07/07/2004 | CN1156277C Rapidlly soluble drug composition |
| 07/07/2004 | CN1156270C Method for producing solid dosing forms |
| 07/07/2004 | CN1156269C Liposome composition having resistance to freeze/thaw damage |
| 07/06/2004 | US6759544 Antimicrobially active acesulfame complexes, process for their preparation and their use |
| 07/06/2004 | US6759509 Branched peptide linkers |
| 07/06/2004 | US6759434 Anti-infective compositions, methods and systems for treating disordered tissue |
| 07/06/2004 | US6759431 Compositions and methods for treating or preventing diseases of body passageways |
| 07/06/2004 | US6759398 Anti-inflammatory androstane derivative |
| 07/06/2004 | US6759387 Delivery enhancing transporter that has sufficient guanidino or amidino sidechain moieties to enhance delivery of a compound conjugated to the reagent across one or more layers of the tissue |
| 07/06/2004 | US6759059 Fentanyl composition for the treatment of acute pain |
| 07/06/2004 | US6759058 Enteric-coated proliposomal formulations for poorly water soluble drugs |
| 07/06/2004 | US6759056 For therapeutic and cosmetic application |
| 07/06/2004 | US6759055 Yeast cells having been cultured in the presence of an alternating electric field having a frequency of 9700 to 9850 mhz and a field strength of 150 to 510 mv/cm |
| 07/06/2004 | US6759050 Stable; recombinant adeno-associated virus (raav) virions that provide protection against loss of transduceability due to manipulation, storage, transport; a dihydric or polyhydric alcohol; polyethylene glycol, propylene glycol, sorbitol |
| 07/06/2004 | US6759049 Pharmaceutical or dietetic mushroom-based compositions |
| 07/06/2004 | US6759029 Aerosols |
| 07/06/2004 | US6759028 Treating arteriovenous malformations by use of radioactive compositions; in vivo delivery of radioactive compositions which are delivered as a fluid to one or more vascular sites and solidified |
| 07/06/2004 | CA2433080C Stable enzymatic wound debrider |
| 07/06/2004 | CA2251816C Sustained release heterodisperse hydrogel systems - amorphous drugs |
| 07/06/2004 | CA2088831C Photocurable glycosaminoglycan derivatives, crosslinked glycosaminoglycans and method of production thereof |
| 07/01/2004 | WO2004055164A2 System and method for stabilizing antibodies with histidine |
| 07/01/2004 | WO2004055042A1 Biologically active peptide conjugates |
| 07/01/2004 | WO2004054904A1 Extendable belt conveyor |
| 07/01/2004 | WO2004054622A1 Immunoconjugates with an intracellularly-cleavable linkage |
| 07/01/2004 | WO2004054621A1 Water-soluble clathrates of ziprasidone and its salts, and the preparation methods therefor |
| 07/01/2004 | WO2004054620A1 Induction of tolerance through oral administration of a therapeutic agent coupled to a transporting agent |
| 07/01/2004 | WO2004054615A1 Antilymphoma targeting agents with effector and affinity functions linked by a trifunctional reagent |
| 07/01/2004 | WO2004054605A1 Freeze-dried interferon-ϝ composition for transpulmonary administration and inhalation system therefor |
| 07/01/2004 | WO2004054602A1 Orally administerable protein preparation and method of orally administering the same |
| 07/01/2004 | WO2004054600A1 Pharmaceutical compound containing silymarin and carbopol®, production method thereof and use of same as a regenerator of tissue and pancreatic cells with endogenous secretion damaged by diabetes mellitus |
| 07/01/2004 | WO2004054589A1 Intravitreally-injectable solution for the treatment of vitreous haemorrhages |
| 07/01/2004 | WO2004054580A1 Tiotropium containing hfc solution formulations |
| 07/01/2004 | WO2004054576A1 Pharmaceutical compositions of sertaconazole for vaginal use |
| 07/01/2004 | WO2004054574A1 Solid drug for oral use |
| 07/01/2004 | WO2004054557A2 Treatment of mastalgia with 4-hydroxy tamoxifen |
| 07/01/2004 | WO2004054555A1 Novel dry powder inhalation system for transpulmonary administration |
| 07/01/2004 | WO2004054552A1 Transdermal composition of an antivomiting agent |
| 07/01/2004 | WO2004054549A1 A topical nanoparticulate spironolactone formulation |
| 07/01/2004 | WO2004054547A1 Stable topiramate formulations |
| 07/01/2004 | WO2004054544A1 Pharmaceutical composition for transdermal or transmucous administration comprising a progestin or an estrogen, method for preparing same and uses thereof |
| 07/01/2004 | WO2004054543A1 Process for the chemical stabilization of a solubilized retinoid in a solvent using a base |
| 07/01/2004 | WO2004054541A2 Ketoprofen compositions and methods of making them |
| 07/01/2004 | WO2004054391A1 A process for the preparation of antioxidant conserve from indian curry leaves (murraya koenigii spreng.) |
| 07/01/2004 | WO2004054356A2 Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent |
| 07/01/2004 | WO2004039944A3 Tri-block polymers for nanosphere-based drug or gene delivery |
| 07/01/2004 | WO2004037197A3 Antifungal formulations |